정수처리 과정에서의 미량오염물질의 거동 및 제거 특성 = Fates and Removals of Micropollutants in Drinking Water Treatment

다국어 초록 (Multilingual Abstract)

Micropollutants emerge in surface water through untreated discharge from sewage and wastewater treatment plants (STPs and WWTPs). Most micropollutants resist the conventional systems in place at water treatment plants (WTPs) and survive the production of tap water. In particular, pharmaceuticals and endocrine disruptors (ECDs) are micropollutants frequently detected in drinking water. In this review, we summarized the distribution of micropollutants at WTPs and also scrutinized the effectiveness and mechanisms for their removal at each stage of drinking water production. Micropollutants demonstrated clear concentrations in the final effluents of WTPs. Although chronic exposure to micropollutants in drinking water has unclear adverse effects on humans, peer reviews have argued that continuous accumulation in water environments and inappropriate removal at WTPs has the potential to eventually affect human health. Among the available removal mechanisms for micropollutants at WTPs, coagulation alone is unlikely to eliminate the pollutants, but ionized compounds can be adsorbed to natural particles (e.g. clay and colloidal particles) and metal salts in coagulants. Hydrophobicities of micropollutants are a critical factor in adsorption removal using activated carbon. Disinfection can reduce contaminants through oxidation by disinfectants (e.g. ozone, chlorine and ultraviolet light), but unidentified toxic byproducts may result from such treatments. Overall, the persistence of micropollutants in a treatment system is based on the physico-chemical properties of chemicals and the operating conditions of the processes involved. Therefore, monitoring of WTPs and effective elimination process studies for pharmaceuticals and ECDs are required to control micropollutant contamination of drinking water.

참고문헌 (Reference)

1 Yiasoumi W, "Water disinfecting techniques for plant pathogen control" 55 : 138-, 2005

2 Jolley RL, "Water chlorination: environmental impact and health effects. Volume 2" Ann Arbor Science Publishers, Inc 78-220, 1978

3 "United states environmental protection agency. Water: contaminants of emerging concern"

4 Dodd MC, "Transformation of the antibacterial agent sulfamethoxazole in reactions with chlorine: kinetics, mechanisms, and pathways" 38 (38): 5607-5615, 2004

5 Pinkston KE, "Transformation of aromatic ether-and amine-containing pharmaceuticals during chlorine disinfection" 38 (38): 4019-4025, 2004

6 Bedner M, "Transformation of acetaminophen by chlorination produces the toxicants 1, 4-benzoquinone and N-acetyl-p-benzoquinone imine" 40 (40): 516-522, 2006

7 Thomas PM, "Tracking acidic pharmaceuticals, caffeine, and triclosan through the wastewater treatment process" 24 (24): 25-30, 2005

8 Melton TC, "The fate of sulfamethazine in sodium-hypochlorite-treated drinking water: monitoring by LC-MSn-IT-TOF" 2012 : 1-6, 2012

9 Richardson ML, "The fate of pharmaceutical chemicals in the aquatic environment" 37 (37): 1-12, 1985

10 Huerta-Fontela M, "Stimulatory drugs of abuse in surface waters and their removal in a conventional drinking water treatment plant" 42 (42): 6809-6816, 2008

11 Korea Pharmaceutical Manufacturers Association, "Statistics of Korea Pharmaceutical Manufacturers Association"

12 Prevedouros K, "Sources, fate and transport of perfluorocarboxylates" 40 (40): 32-44, 2006

13 Rogers HR, "Sources, behaviour and fate of organic contaminants during sewage treatment and in sewage sludges" 185 (185): 3-26, 1996

14 Snyder SA, "Role of membranes and activated carbon in the removal of endocrine disruptors and pharmaceuticals" 202 (202): 156-181, 2007

15 Assmuth T, "Research for management of environmental risks from endocrine disruptors, 448"

16 Roccaro P, "Removal of xenobiotic compounds from wastewater for environment protection: treatment processes and costs" 32 : 505-510, 2013

17 Vieno N, "Removal of pharmaceuticals in drinking water treatment: effect of chemical coagulation" 27 (27): 183-192, 2006

18 Carballa M, "Removal of pharmaceuticals and personal care products (PPCPs) from municipal wastewaters by physico-chemical processes" 2 (2): 309-313, 2003

19 Rossner A, "Removal of emerging contaminants of concern by alternative adsorbents" 43 (43): 3787-3796, 2009

20 Carballa M, "Removal of cosmetic ingredients and pharmaceuticals in sewage primary treatment" 39 (39): 4790-4796, 2005

21 Adams C, "Removal of antibiotics from surface and distilled water in conventional water treatment processes" 128 (128): 253-260, 2002

22 Choi KJ, "Removal of antibiotics by coagulation and granular activated carbon filtration" 151 (151): 38-43, 2008

23 Ternes TA, "Removal of Pharmaceuticals during Drinking Water Treatment" 36 (36): 3855-3863, 2002

24 Sang Goo Kim, "Removal efficiencies of endocrine disrupting chemicals by coagulation/flocculation, ozonation, powdered/granular activated carbon adsorption, and chlorination" 한국화학공학회 23 (23): 399-408, 2006

25 Hu JY, "Products of aqueous chlorination of 4-nonylphenol and their estrogenic activity" 21 (21): 2034-2039, 2002

26 Suarez S, "Pre-treatment of hospital wastewater by coagulation flocculation and flotation" 100 (100): 2138-2146, 2009

27 Kumar A, "Pharmaceuticals, personal care products and endocrine-disrupting chemicals in U.S. surface and finished drinking waters: A proposed ranking system" 408 (408): 5972-5989, 2010

28 Caliman FA, "Pharmaceuticals, personal care products and endocrine disrupting agents in the environment a review" 37 (37): 277-303, 2009

29 Benotti M, "Pharmaceuticals and endocrine disrupting compounds in US drinking water" 43 (43): 597-603, 2009

30 Zoeteman B, "Persistent organic pollutants in river water and ground water of the Netherlands" 9 : 231-249, 1980

31 Gibs, J, "Persistence of pharmaceuticals and other organic compounds in chlorinated drinking water as a function of time" 373 (373): 240-249, 2007

32 Stackelberg PE, "Persistence of pharmaceutical compounds and other organic wastewater contaminants in a conventional drinking-watertreatment plant" 329 (329): 99-113, 2004

33 Halling-SØrensen B, "Occurrence, fate and effects of pharmaceutical substances in the environment-a review" 36 (36): 357-393, 1998

34 Vieno N, "Occurrence of pharmaceuticals in Finnish sewage treatment plants, surface waters, and their elimination in drinking water treatment processes" Tampere University of Technology 28-34, 2007

35 Ratola N, "Occurrence of organic microcontaminants in the wastewater treatment process. A mini review" (239-240) : 1-18, 2012

36 Huerta-Fontela M, "Occurrence and removal of pharmaceuticals and hormones through drinking water treatment" 45 (45): 1432-1442, 2011

37 Kim SD, "Occurrence and removal of pharmaceuticals and endocrine disruptors in South Korean surface, drinking, and waste waters" 41 (41): 1013-1021, 2007

38 Sim WJ, "Occurrence and fate of pharmaceuticals in wastewater treatment plants and rivers in Korea" 158 (158): 1938-1947, 2010

39 Grundwasser KiBO-u, "Occurrence and distribution of organic contaminants in the aquatic system in Berlin. Part I: Drug residues and other polar contaminants in Berlin surface and groundwater" 26 (26): 272-278, 1998

40 "Network of reference laboratories for monitoring of emerging environmental pollutions in Europe. Why do we need to address emerging substances ?"

41 Heasley VL, "Investigations of the structure and reactions of the intermediate in the chlorination of resorcinol" 12 (12): 1653-1659, 1993

42 Quintana JB, "Investigating the chlorination of acidic pharmaceuticals and by-product formation aided by an experimental design methodology" 44 (44): 243-255, 2010

43 "International environment forum. IEF sustapedia an encyclopedia of sustainability"

44 World Health Organization, "IARC Monographs on the evaluation of carcinogenic risks to humans. Vol. 79, spplement 7"

45 Gregory J, "Hydrolyzing metal salts as coagulants" 73 (73): 2017-2026, 2001

46 Kumar A, "Human health risk assessment of pharmaceuticals in water: issues and challenges ahead" 7 (7): 3929-3953, 2010

47 "Hazardous substances data bank. Comprehensive, peer-reviewed toxicology data for about 5,000 chemicals"

48 Heberer T, "From municipal sewage to drinking water: fate and removal of pharmaceutical residues in the aquatic environment in urban areas" 46 (46): 81-88, 2002

49 Westerhoff P, "Fate of endocrine-disruptor, pharmaceutical, and personal care product chemicals during simulated drinking water treatment processes" 39 (39): 6649-6663, 2005

50 McLachlan J, "Fate and analysis of pharmaceutical residues in the aquatic environment" 948 : 153-, 2001

51 "European environment agency. Environmental terminology and discovery service (ETDS)"

52 Birkett JW, "Endocrine disrupters in wastewater and sludge treatment processes" CRC Press 5-7, 2003

53 Stackelberg PE, "Efficiency of conventional drinking-water-treatment processes in removal of pharmaceuticals and other organic compounds" 377 (377): 255-272, 2007

54 Hari AC, "Effects of pH and cationic and nonionic surfactants on the adsorption of pharmaceuticals to a natural aquifer material" 39 (39): 2592-2598, 2005

55 Richardson SD, "Disinfection by-products and other emerging contaminants in drinking water" 22 (22): 666-684, 2003

56 Sojic D, "Degradation of thiamethoxam and metoprolol by UV, O3 and UV/O3 hybrid processes: Kinetics, degradation intermediates and toxicity" (472-473) : 314-327, 2012

57 Nguyen LN, "Comparison between sequential and simultaneous application of activated carbon with membrane bioreactor for trace organic contaminant removal" 130 : 412-417, 2012

58 Duan J, "Coagulation by hydrolysing metal salts" (100- 102) : 475-502, 2003

59 Gallard H, "Chlorination of phenols: Kinetics and formation of chloroform" 36 (36): 884-890, 2002

60 Yamamoto T, "Chlorination of bisphenol A in aqueous media: formation of chlorinated bisphenol A congeners and degradation to chlorinated phenolic compounds" 46 (46): 1215-1223, 2002

61 Alexander JT, "Chemical coagulation-based processes for trace organic contaminant removal: Current state and future potential" 111 (111): 195-207, 2012

62 Gledhill W, "Biodegradation of 3, 4, 4’-trichlorocarbanilide, TCC in sewage and activated sludge" 9 (9): 649-654, 1975

63 Boleda MR, "Behavior of pharmaceuticals and drugs of abuse in a drinking water treatment plant (DWTP) using combined conventional and ultrafiltration and reverse osmosis (UF/RO) treatments" 159 (159): 1584-1591, 2011

64 Kim Y, "Aquatic toxicity of acetaminophen, carbamazepine, cimetidine, diltiazem and six major sulfonamides, and their potential ecological risks in Korea" 33 (33): 370-375, 2007

65 Stumm W, "Aquatic chemistry" 25 (25): 1162-, 1996

66 Cantrell KJ, "Applicability of the linear sorption isotherm model to represent contaminant transport processes in site-wide performance assessments" Pacific Northwest National Laboratory 1-6, 2003

67 Ye C, "Alkalinity effect of coagulation with polyaluminum chlorides: Role of electrostatic patch" 294 (294): 163-173, 2007

68 Yu Z, "Adsorption characteristics of selected pharmaceuticals and an endocrine disrupting compound°™Naproxen, carbamazepine and nonylphenol°™on activated carbon" 42 (42): 2873-2882, 2008

69 Summers RS, "Activated carbon adsorption of humic substances: I. Heterodisperse mixtures and desorption" 122 (122): 367-381, 1988

70 Avdeef A, "Absorption and drug development: solubility, permeability, and charge state" Wiley 31-34, 2012